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Early life exposure to microbes plays an important role in immune system development.
Germ-free mice, or mice colonized with a low-diversity microbiota, exhibit high serum IgE
levels. An increase in microbial richness, providing it occurs in a critical developmental
window early in life, leads to inhibition of this hygiene-induced IgE. However, whether
this inhibition is dependent solely on certain microbial species, or is an additive effect
of microbial richness, remains to be determined. Here we report that mice colonized
with a combination of bacterial species with specific characteristics is required to inhibit
IgE levels. These defined characteristics include the presence in early life, acetate
production and immunogenicity reflected by induction of IgA. Suppression of IgE did
not correlate with production of the short chain fatty acids propionate and butyrate,
or induction of peripherally induced Tregs in mucosal tissues. Thus, inhibition of IgE
induction can bemediated by specificmicrobes and their associatedmetabolic pathways
and immunogenic properties.
Keywords: microbiota, IgE, Tregs, SCFA, gnotobiotic
INTRODUCTION
The prevalence of allergies has been increasing over the last 50 years. The hygiene hypothesis
postulated a link between decreased microbial exposure and increased type 2 immune responses
(1). Later observations revealed that increased hygiene led to changes in both allergic and
autoimmune diseases, leading to the counter-regulatory model (2, 3). Growing understanding of
the impact of the intestinal microbiome on immune regulation led to formulation of the microflora
hypothesis, which suggested that changes in the composition and richness of gut microbial
communities underlies allergic diseases (4). Indeed, many studies now support the suggestion
that microbial colonization during a critical window in early life is particularly important for
development of a regulated immune system in both mice and man (5).
Elevated total serum IgE levels are a hallmark of allergies but are also observed in multiple
immunodeficiencies, including some characterized by deficiencies in regulatory T cells (6, 7). We
have previously shown that hyper-IgE is associated with an underlying immune dysregulation or
deficiency (8). In line with this, germ-free mice display abnormally high serum IgE levels (8–11).
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Wehave previously shown that exposure to an increased diversity
of microbes in early life, during a “window of opportunity,”
could completely inhibit these high serum IgE levels (11).
However, it was unclear whether the inhibition of IgE during
this critical window was an additive result of increased diversity
or rather reflected the presence of a “keystone” microbial
species. The underlying cellular and molecular mechanisms
involved in inhibition of IgE were also unclear. Regulatory
T cells play a major role in suppressing immune responses
to self-antigens, commensal microorganisms, and harmless
environmental antigens (12). Defects in regulatory T cell
induction or function have been associated with the development
of autoimmunity, food allergy and age-dependent unbalanced
Th2 responses atmucosal sites (7, 13–15). There are thought to be
two populations of Tregs; one derived from the thymus, referred
to as tTregs, and another originating from naïve T cells in the
periphery (pTregs) (16).
Intestinal bacteria, such as some Clostridia species, have
been shown to induce pTreg differentiation via their production
of the short chain fatty acid (SCFA) butyrate in the colon
(17, 18). Furthermore, a subpopulation of Tregs, defined as
CD4+Foxp3+RORγt+Helios−, has been shown to be induced
by the microbiota in the small intestine, colon and GALT
tissues (19–21). It is unclear, however, whether there is a
functional link between microbial colonization, pTreg induction,
in particular the RORγt+Helios− pTregs subpopulation, and IgE
regulation. We hypothesized that certain bacterial species and
their production of SCFA could induce the immune regulation
of IgE by increasing peripherally induced pTregs. Here, we
generated an extensive collection of gnotobiotic mouse colonies
and found that three bacterial species that colonize the small
intestine in early life can together suppress hygiene-mediated
hyper-IgE. We identified acetate production, immunogenicity
and mucosa association as key characteristics of bacterial
consortia that when combined provide the capacity to inhibit the
induction of hyper-IgE.
MATERIALS AND METHODS
Mice, Hygiene Status and, Bacterial
Colonization
C57BL/6J mice were re-derived to germ-free status via two-cell
embryo transfer. Axenic and gnotobiotic mice (germ-free and
precisely colonized) were bred and maintained in flexible-film
isolators at the Clean Mouse Facility (CMF), University of Bern,
Switzerland or at the International Microbiome Centre (IMC),
University of Calgary, Canada. The germ-free and gnotobiotic
C57BL/6J strain used in Bern and Calgary were identical. For
some experiments, mice were housed in individually ventilated
isocages (Tecniplast) in the IMC. Germ-free status was routinely
monitored by culture-dependent and—independent methods
and all germ-free colonies were independently confirmed to
be pathogen-free. To start gnotobiotic mouse colonies, germ-
free breeding pairs were gavaged with single or mixed bacterial
cultures, as indicated. Gram staining, SYTOXTM (Fisher) DNA
staining and 16S rRNA gene amplicon sequencing of their
intestinal contents were performed to confirm their colonization
status. The offspring of these gnotobiotic breeding pairs were
analyzed at 10–13 weeks of age, unless stated otherwise. SPF
mice were either purchased from Envigo (Switzerland) or bred
and maintained at the University of Calgary. The SPF mice at
the University of Calgary were fed the same autoclaved diet
as their germ-free and gnotobiotic counterparts. Although two
different SPF colonies were used, one in Switzerland (Envigo,
Netherlands) and another in Canada (in house SPF colony)
we did not observe any significant differences in our readouts
between these two SPF colonies. The only data derived from
Envigo SPF mice are n = 18 of a total of n = 80 mice shown in
Figure 1B as well as the data shown in Supplementary Figure 3.
All animal experiments were in accordance with the guidelines
established by either the Swiss Federal Veterinary Office or by
the Canadian Council for Animal Care and were approved by
the Commission for Animal Experimentation of the Veterinary
Office of Canton Bern or by the University of Calgary Animal
Care Committee.
Bacterial Culture
Bacteria were cultured in Brain Heart Infusion (BHI) medium
as previously described (22). Bottles and media were gassed
with 10% H2, 10% CO2, and 80% N2 while in a Whitley A95
anaerobic incubator before being sealed and inoculated with
specific bacterial species.
Bacterial Flow Cytometry
Bacterial flow cytometry was performed as described previously
(23, 24). Briefly, bacteria were cultured for 24–48 h as
described above, with the modification that the BHI media
was filter-sterilized before inoculation. For growing Akkermansia
muciniphila YL44, 0.25 g/L of autoclaved Type II hog
gastric mucin (Sigma) was added to the filter-sterilized BHI
media. Bacterial cultures were centrifuged for 10min at
3,000 g, washed twice and re-suspended in sterile-filtered
PBS/2%BSA/0.02% sodium azide and diluted to∼107 bacteria/ml
(OD595 0.1 = 10
8 bacteria/ml). Serum was diluted 1:10 in
PBS/2%BSA/0.02% sodium azide, heat-inactivated at 56◦C for
30min and centrifuged at 16,000 g for 5min at 4◦C to remove
any bacteria sized contaminants. This serum supernatant was
used to perform serial dilutions. 2.5 × 105 bacteria were added
to each well and incubated with the serial dilutions of serum
for 1 h at 4◦C, centrifuged for 10min at 3,000 g, washed twice
and then re-suspended in monoclonal APC rat anti-mouse IgG1
(1:40, A85-1) (BD) and BV605 rat anti-mouse IgA (1:40, C10-1)
(BD) and incubated overnight at 4◦C. The bacteria were washed
twice in PBS/2%BSA/0.02% sodium azide and then re-suspended
in PBS/2%BSA/0.02% sodium azide and acquired on a FACS
Canto (BD) using FSc (forward scatter) and SSc (side scatter)
in logarithmic mode. Data was analyzed using FlowJo software
(Tree Star Inc.).
Small Intestinal Wash Collection
The entire small intestine was removed and washed with 5ml of
ice-cold intestinal wash buffer [10% 0.5M EDTA pH 8.0, 10%
10x PBS, ddH2O and 0.1mg ml
−1 soybean trypsin inhibitor
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FIGURE 1 | A butyrate-producing bacterial species cannot regulate serum IgE levels (A) Relative species abundance in the small intestine (SI) and cecum of a
representative C1- and C2-colonized mouse, n = 3–4 mice per group. (B) Total serum IgE levels in germ-free (GF) (n = 113), C1 (n = 15), C2 (n = 28), and SPF (n =
80) mice. (C) SCFA levels in the cecal contents of GF (n = 15–16), C1 (n = 4), C2 (n = 6–10), and SPF (n = 13–14) mice. Each symbol represents an individual
mouse. Black horizontal lines depict the geometric mean (B) or mean (C). All mice were 10–13 weeks old. *p < 0.05, **p < 0.01, ****p < 0.0001, calculated by
one-way ANOVA with Tukey’s (B) or Dunnett’s (C) post-test.
(Sigma)] with 40 µl of 100µM phenylmethylsulfonylfluoride
(PMSF, Sigma) per 5ml of intestinal wash buffer. The small
intestinal wash was centrifuged at 4,000 g for 10min at 4◦C and
stored at−80◦C.
DNA Extraction From Intestinal Contents
Small intestines, ceca and colons were opened longitudinally.
Contents were removed and snap-frozen in liquid nitrogen and
stored at−80◦C. DNA was extracted from the contents using the
QIAamp Fast DNA Stool Mini Kit (Qiagen), according to the
manufacturer’s instructions. Briefly, samples were homogenized
in InhibitEX buffer by bead-beating using differentially sized
beads (glass beads, 0.5–0.75mm; zirconia beads, <100µM),
treated with lysis buffer (1.2% Triton X-100, 2mMEDTA, 20mM
Tris·HCl) containing lysozyme (20mgml−1, Sigma), followed by
Proteinase K treatment. Bacterial DNA was ethanol-precipitated
on a column membrane and eluted with sterile water. Procedural
blank DNA extractions were performed in parallel with each
batch of DNA extractions and run as controls during the
downstream PCR steps to confirm the absence of contaminating
DNA sequences from the extraction process.
16S rRNA Gene Amplicon Sequencing
Two platforms were used for 16S rRNA gene
amplicon sequencing.
For the gnotobiotic models C1 and C2
(Supplementary Table 1) the 16S rRNA gene segments spanning
the variable V5 and V6 regions were amplified from DNA
from intestinal content samples using a multiplex approach
with the barcoded forward fusion primer 5′-CCATCTCA
TCCCTGCGTGTCTCCGACTCAG BARCODE ATTAGAT
ACCCYGGTAGTCC-3′ in combination with the reverse fusion
primer 5′-CCTCT CTATGGGCAGTCGGTGATACGAGCTG
ACGACARCCATG-3′. The sequences in italics are Ion torrent
PGM-specific adaptor sequences. The PCR amplified 16S rRNA
V5-V6 amplicons were purified and prepared for sequencing
on the Ion torrent PGM system according to the manufacturer’s
instructions (Life Technologies). Samples with over 1,000
reads were used for the analysis. Data analysis was performed
using the QIIME pipeline version 1.8.0 (25). Operational
taxonomic units were picked using UCLUST (26) with a 97%
sequence identity threshold followed by taxonomy assignment
using a custom C1 or C2 database for gnotobiotic C1 and
C2 intestinal samples. For all other gnotobiotic models, the
16S rRNA gene segment spanning the variable V4 region
was amplified from DNA extracted from intestinal content
samples using a multiplex approach with the barcoded forward
fusion primer 5′- AATGATACGGCGACCACCGAGAT
CTACAC i5BARCODE TATGGTAATTGTGTGCCAGCMG
CCGCGGTAA-3′ in combination with the reverse fusion
primer 5′CAAGCAGAAGACGGCATACGAGAT i7BARCODE
AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT-3′. One
PCR reaction contained 0.25mM of each primer, KAPA HiFi
Hot Start Ready Mix (Roche) and 20–100 µg of template DNA.
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PCR conditions were 98◦C for 2min, followed by 25 cycles
of 98◦C for 30 s, 55◦C for 30 s and 72◦C for 20 s and a final
extension step at 72◦C for 7min. Amplification of the V4 gene
region was verified by electrophoresis on a 1.2% agarose gel.
Reactions were purified using NucleoMag NGS clean-up beads
(Macherey-Nagel) and were normalized using the SequalPrep
Normalization Plate Kit (Invitrogen). Amplicons were pooled
and concentration and quality were determined using the Qubit
HS DNA kit (Qubit) and the Tapestation D1000 assay (Agilent),
respectively. Amplicon sequencing was done on a MiSeq
Benchtop DNA sequencer (Illumina) using a V2-500 cycle kit
(Illumina Inc.). Using the Dada2 (27), the phyloseq (28) and the
reshape2 packages (29) within R (30), forward and reverse reads
were trimmed to 230 and 210 bp, respectively, and chimeras were
removed using the removeBimeraDenovo function. Taxonomy
was assigned using custom databases containing the 16S rRNA
gene sequences of all the bacterial species used in the gnotobiotic
models. Amplicon sequence variants (ASVs) that were present at
<0.5% were excluded.
16S rRNA Gene Full Length Sequencing
To confirm monocolonization status feces were collected from
monocolonized mice and DNA was extracted. 16S rRNA full
length PCR was performed using forward primers fD1 5′-
AGA GTT TGA TCC TGG CTC AG-3′ and fD2 5′-AGA
GTT TGA TCA TGG CTC AG-3′ and the reverse primer
rP1 5′ACG GTT ACC TTG TTA CGA CTT-3′ (31). Each
PCR reaction contained 0.2µM of each primer, 1X Green
GoTaq R© Flexi buffer (Promega), 0.2mM dNTP (Promega),
1.25 Units of GoTaq R© DNA polymerase (Promega) and 100
ng of extracted fecal DNA. PCR conditions were 94◦C for
5min, followed by 35 cycles of 94◦C for 1min, 43◦C for
1min and 72◦C for 2min and a final extension step at
72◦C for 7min. PCR products were submitted for Sanger
sequencing and sequencing results were blasted against the NCBI
blast database.
Cell Isolation and Intracellular Cytokine
Staining
The entire small intestine and the entire colon were excised
and the residual fat and Peyer’s patches (PP) were removed.
The intestines were opened longitudinally, rinsed in Dulbecco’s
Phosphate-Buffered Saline (DPBS) lacking CaCl2 and MgCl2
(Invitrogen), cut into 1-2 cm long pieces and washed once
(colon) or twice (small intestine) in 25ml of Hank’s balanced
salt solution (HBSS) containing 0.5mM EDTA, 10mM HEPES
and 5% Horse serum (HS) for 20min at 37◦C with shaking at
220 rpm in order to remove the epithelial layer. Here HBSS
consisted of 5.4mM KCl, 0.3mM NaH2PO4, 0.4mM KH2PO4
and 137mM NaCl. Residual tissue was rinsed with DPBS and
transferred into HBS/5% HS solution (HBSS with 10mMHEPES
and 25mM NaHCO3) containing 1.0mg ml
−1 collagenase Type
VIII (Sigma) and 10UDNAse I (Roche) andminced and digested
for 20–30min (small intestine) or 25–35min (colon) at 37◦C
with shaking at 220 rpm. The resulting cell suspension was
passed through a cell strainer (100µM). Cells were washed with
HBS/5%HS and centrifuged at 400 g for 5min and re-suspended
for quantification.
For Figure 3, after digestion and centrifugation the small
intestine cell pellet was re-suspended in 40% Percoll solution
and layered on top of a 70% Percoll solution (GE Healthcare).
Gradient centrifugation was carried out at 700 g for 20min
at room temperature with no break. Cells lying at the
40%/70% interphase were collected and washed with HBS/5%
HS and centrifuged at 400 g for 5min and re-suspended for
quantification. Mesenteric lymph nodes (MLNs) and PP were
digested with HBS/5%HS containing 1mg ml−1 collagenase
IA (Sigma) and 10U DNAse I (Roche) for 20min at 37◦C
and passed through a cell strainer (100µM), washed with
HBS/5%HS and centrifuged at 400 g for 5min and re-suspended
for quantification. Spleens were passed through a cell strainer
(100µM) and centrifuged at 400 g for 5min. Spleen cell pellets
were re-suspended in 1ml of 0.88% NH4Cl for 10min at room
temperature to lyse red blood cells. Cells were washed with
HBS/5%HS and centrifuged at 400 g for 5min and re-suspended
for quantification.
For intracellular cytokine staining small intestinal single cell
suspensions were stimulated for 4 h at 37◦C/5% CO2 in Iscove’s
Modified Dulbecco’s Media (IMDM, Fisher) containing 10%
Fetal Bovine Serum (FBS, Fisher) in the presence or absence
of 50 ng ml−1 phorbol 12-myristate 13-acetate (PMA, Sigma)
and 750 ng ml−1 ionomycin (Invitrogen) with 10 µg ml−1
Brefeldin A (Sigma).
Flow Cytometry
Cells were washed twice with DPBS and stained with either
fixable viability dye eFluor506 (eBioscience) or fixable viability
stain 780 (BD) and anti-CD16/CD32 (2.4G2; BD) in DPBS
for 10min at 4◦C. Cells were then washed with FACS buffer
containing 2% fetal calf serum (Invitrogen), 2.5mM EDTA
(MP Biomedicals) in PBS. For cell surface staining, cell pellets
were re-suspended in antibodies diluted in FACS buffer and
stained for 30min at 4◦C. Intra-nuclear staining was performed
using the Foxp3 staining kit (eBioscience). Intracellular cytokine
staining was performed with the Cytofix/Cytoperm staining
kit (BD). The following mouse-specific conjugated antibodies
were used: CD45-PerCP-Cy5.5 (30-F11; BD), CD45-BV510 (30-
F11; BD), TCRβ-BV786 (H57-597; BD), CD4-Pe-Cy7 (RM4-
5; BD), Helios-AlexaFluor488 (22F6; BD), CD3-PB (145-
2C11; Biolegend), CD4-BV785 (RM4-5; Biolegend), Helios-FITC
(22F6; Biolegend), IL10-Pe-Cy7 (JES5-16E3; Biolegend) Foxp3-
AlexaFluor700 (FJK-16s; eBioscience), and RORγt-PE (Q31-
378; eBioscience). Cells were acquired on a FACS Fortessa (BD
Biosciences) or a FACS Canto (BD) with FACSDIVA software
(BD). Data analysis was performed using FlowJo software
(Tree Star Inc.).
IgE ELISA and IgE
Electrochemiluminescence Immunoassay
(IgE-ECL)
Blood was collected in serum-separating tubes (Sarstedt and
BD) and total serum IgE concentrations were measured
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FIGURE 2 | An increase in microbial diversity does not inhibit hyper-IgE despite pTreg induction. (A) Relative species abundance in the small intestine (SI) and cecum
of a representative C3- and C4-colonized mouse, n = 3 mice per group. (B) Total serum IgE levels in C3 (n = 31) and C4 (n = 56) mice. The blue and orange
horizontal lines represent the geometric mean of the GF and SPF cohorts, respectively (from Figure 1B). (C) SCFA levels in the cecal contents of C3 (n = 10–13) and
C4 (n = 7–9) mice. The orange and brown horizontal lines represent the mean of the SPF and C2 cohorts, respectively (from Figure 1C). (D) Representative flow
cytometry plots of RORγt+Helios− Tregs in different tissues (Spl, spleen; PP, Peyer’s patches; MLN, mesenteric lymph nodes; SI, small intestinal lamina propria; Col,
colon lamina propria) of GF, C3, C4 and SPF mice. (E) Frequencies of RORγt+Helios− Tregs among CD45+TCRβ+CD4+Foxp3+ T cells in different tissues of GF (n =
10–15), C3 (n = 4–9), C4 (n = 4–8), and SPF (n = 7–16) mice. All mice were 10–13 weeks old. SCFA and RORγt+Helios− Treg data are pooled from at least two
independent experiments. Each symbol represents an individual mouse. Black horizontal lines depict the geometric mean (B) or mean (C,E). *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001, calculated by one-way ANOVA with Tukey’s (B,E) or Dunnett’s (C) post-test.
using either the BD OptEIA Mouse IgE ELISA Set (BD)
according to the manufacturer’s instructions, or a multi-array
(Meso Scale Discovery) utilizing the BD OptEIA Mouse IgE
ELISA Set.
IgA and IgG1 Electrochemiluminescence
Immunoassay
Total concentrations of IgA and IgG1 in serum and small
intestinal wash were determined using the Mouse Isotyping
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FIGURE 3 | A further increase in microbial diversity suppresses hyper-IgE and demonstrates a dynamic bacterial colonization profile in the small intestine and colon in
early life. (A) Relative species abundance in the small intestine (SI) and cecum of a representative adult Oligo-MM12 mouse, n = 4 mice. (B) Total serum IgE levels in
Oligo-MM12 (n = 100) mice. The blue and orange horizontal lines represent the geometric mean of the serum IgE levels from the GF and SPF cohorts, respectively
(Continued)
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FIGURE 3 | (from Figure 1B). (C) SCFA levels in the cecal contents of Oligo-MM12 (n = 19) mice. The orange and purple horizontal lines represent the mean SCFA
levels in the SPF and C4 cohorts, respectively (from Figures 1C, 2C). (D) Representative flow cytometry plots of RORγt+Helios− Tregs in different tissues (Spl,
spleen; PP, Peyer’s patches; MLN, mesenteric lymph nodes; SI, small intestinal lamina propria; Col, colon lamina propria) of Oligo-MM12 mice. (E) Frequencies of
RORγt+Helios− Tregs among CD3ε+CD4+Foxp3+ T cells in different tissues of Oligo-MM12 (n = 12–13) mice. The blue and orange horizontal lines represent the
mean of the GF and SPF cohorts, respectively (from Figure 2E). (F) Relative species abundances of Oligo-MM12 bacterial species in the small intestine and colon of 8
to 43-day old Oligo-MM12 mice. n = 2–5 mice per time point. All mice were 10–13 weeks old (A–E). SCFA and RORγt+Helios− Treg data are pooled from at least two
independent experiments. Each symbol represents an individual mouse. Black horizontal lines depict the geometric mean (B) or mean (C,E). *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001, calculated by one-way ANOVA with Tukey’s (B,E) or Dunnett’s (C) post-test.
Panel 1 kit according to the manufacturer’s instructions (Meso
Scale Discovery).
LC/MS/MS Based Short Chain Fatty Acid
Metabolite Analysis
Cecal contents were collected, snap-frozen in liquid nitrogen and
stored at −80◦C until processed. Native SCFAs were extracted
from cecal samples with an ice-cold 50% acetonitrile solution
(2:1 (v/w) ratio) containing known amounts of the following
13C-SCFA analytical standards used as internal standards
(IS): acetic acid (1,2-13C2, 99%, #CLM-113, Cambridge
Isotope Laboratories, Inc, Andover, MA, USA), Propionic acid
(13C3, 99%, #589586, Sigma-Aldrich, St. Louis, MO, USA)
and Butyric acid (1,2-13C2, 99%, #491993, Sigma-Aldrich)
(Supplementary Table 2). Samples were homogenized at 30Hz
for 3min with a tissue lyzer (Qiagen) and centrifuged at 18,000
g for 10min at 4◦C. Supernatants were collected and centrifuged
under the same conditions. Supernatants were then derivatized
with EDC (N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide
hydrochloride) and aniline (32, 33) as follows: 100 µL aliquot
were incubated with EDC (50mM, final concentration) and
aniline (100mM, final concentration) for 2 h at 4◦C. An aliquot
of each sample was further diluted with 50% HPLC-grade
methanol/water. All samples were stored at 4◦C until analysis on
the same day.
LC-MS/MS analysis of cecal contents was performed on a
VanquishTM UHPLC System coupled to a TSQ QuantumTM
Access MAX triple quadrupole Mass Spectrometer (Thermo
Scientific) equipped with an electrospray ionization (HESI-II)
probe. The UHPLC-MS platform was controlled by XcaliburTM
data system (Thermo Scientific).
Chromatographic separation was achieved on a Hypersil
GOLDTM C18 column (200 X 2.1mm, 1.9µm, Thermo
Scientific) using a binary solvent system composed of LC-MS
grade H2O with 0.1% (%v/v) formic acid (Solvent A) and LC-MS
grade methanol with 0.1% (%v/v) formic acid (solvent B). The
following 21min gradient was used: 0–1min, 40%B; 1–7min, 40–
98%B; 7–15min, 98%B; 15–16min, 98–40%B; 16–21min, 40%B.
LC eluent was diverted to waste for the first 5min of the run. The
flow rate was 200 µL/min and the sample injection volume 2 µL.
The auto sampler was kept at 4◦C and the column at 30◦C.
MS/MS data were acquired in positive ionization mode
with the mass spectrometer operating in Selected Reaction
Monitoring (SRM) mode. Fragmentation parameters were
optimized using the EZ Tune program with direct infusion
of the derivatized analytical grade standards. Subsequently, the
following transitions, corresponding to the three derivatized
native SCFAs and respective derivatized 13C-SCFA standards,
were monitored, with a scan time of 0.05 s and a fixed collision
energy of 14 eV: [M+H]+ m/z 136.07, 138.08, 150.09, 153.10,
164.10, 166.11 → m/z 94.06. Electrospray ionization source
conditions were as follows: spray voltage of 3,000V, vaporizer
temperature of 300◦C, sheath gas of 5 (arbitrary units), sweep gas
of 1 (arbitrary units), auxiliary gas of 2 (arbitrary units), capillary
temperature of 275◦C.
Data analyses, on the converted mzXML files, were conducted
in MAVEN (34, 35). In short, for each SCFA, the determination
of the native SCFA concentration was based on the 12C/13C signal
intensity ratio and the respective 13C-IS concentration.
Statistical Analysis
Statistical analysis was performed by one-way ANOVA with
Tukey’s or Dunnett’s post-test depending on whether the
comparison was performed between all means (Tukey’s) or
compared to a control mean (Dunnett’s) using GraphPad Prism 8
(GraphPad Software Inc.). The data for serum IgE concentrations
was first log transformed before performing one-way ANOVA
with Tukey’s post-test. The SCFA in colon vs. cecum (in
Supplementary Figure 1) were compared using Student’s t-test.
A p < 0.05 was considered statistically significant. P-values are
indicated as follows: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p <
0.0001, not significant (ns).
RESULTS
The Presence of a Butyrate-Producing
Bacterial Species Has a Minimal Effect on
Adult Serum IgE Levels
We have previously shown that mice colonized with the
Altered Schaedler Flora (ASF), harboring eight commensal
intestinal bacterial species (36), display a dichotomy in terms
of development of high IgE levels (11). High IgE levels in
adulthood correlated with a low ASF diversity early in life
while a high ASF diversity early in life suppressed induction
of IgE. We also noted that the presence of the butyrate-
producing bacteria Pseudoflavonifractor sp. ASF500 early in
life correlated with suppression of IgE (11). We and others
have also previously shown that ASF colonization (37) or
colonization with microbial consortia containing Clostridia
species (38, 39) results in the induction of intestinal pTregs
and the SCFA butyrate has been demonstrated to support
pTreg induction (17, 18). To test whether butyrate produced by
Pseudoflavonifractor sp. ASF500 could suppress hyper-IgE, we
gavaged germ-free C57BL/6 breeding pairs with either microbial
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Community #1 (C1, Supplementary Table 1) consisting of three
non-butyrate-producing ASF species we know do not suppress
hyper-IgE, or community C2, which had the butyrate-producer
Pseudoflavonifractor sp. ASF500 added to the community
(Supplementary Table 1). This approach was necessary because
Pseudoflavonifractor sp. ASF500 is unable to colonize a germ-
free mouse on its own and requires the presence of other
bacterial species (data not shown). Colonization with either
C1 or C2 in the small intestine and cecum of the offspring
was confirmed by 16S rRNA amplicon sequencing (Figure 1A).
Pseudoflavonifractor sp. ASF500 was only detected in the C2
group and Lactobacillus intestinalis ASF360 (present in the
inoculum for C1 and C2) was below the detection limit in
both groups.
Total serum IgE levels were measured in large control cohorts
of GF and specific pathogen free (SPF) mice (Figure 1B). As
previously shown (11), IgE levels in adult GF mice were elevated
and significantly increased above SPF levels. We found that
IgE levels in adult C1- or C2-colonized offspring remained
significantly elevated at the level of GF controls (Figure 1B). We
found that colonization with both C1 and C2 led to significant
increases in acetate and propionate levels compared to GF levels,
whereas only C2 significantly increased butyrate levels in the
cecal contents, as expected (Figure 1C). All SCFA levels in the
C1 and C2 cohorts remained significantly lower than that found
in SPF mice (Figure 1C). These data indicated that low levels of
SCFA were insufficient to inhibit hygiene-induced hyper-IgE. Of
note, SCFA levels in cecal contents were comparable to the levels
observed in colon contents (Supplementary Figure 1).
A Further Increase in Microbial Diversity
Does Not Inhibit Hyper-IgE Despite
Induction of pTregs
We next investigated whether sequentially increasing bacterial
diversity would lead to suppression of hyper-IgE. We therefore
added Clostridium sp. ASF356 to the C2 community to form
community C3 and added Clostridium sp. ASF502 to C3
to generate C4 (Supplementary Table 1). 16S rRNA amplicon
sequencing of small intestinal and cecal contents from adult
C3- and C4-colonized offspring confirmed the presence of
Clostridium sp. ASF356 in both C3- and C4-colonized mice and
Clostridium sp. ASF502 only in C4-colonized mice (Figure 2A).
Despite the increase inmicrobial richness, serum IgE levels in C3-
and C4-colonized mice remained comparable to GF levels and
significantly elevated compared to SPF IgE levels (Figure 2B).
Furthermore, despite the increase in microbial richness, SCFA
levels in cecal content from C3- and C4-colonized mice did not
differ from those found in C2-colonized mice (Figure 2C). Since
regulatory T cells are thought to be important in regulating Type
2 immunity (19), we next assessed induction of Tregs (gating
strategy shown in Supplementary Figure 2A). We found that
although there was only a minimal effect on the proportions and
total numbers of Foxp3+ Tregs (Supplementary Figures 2B–D),
colonization with both C3 and C4 led to significant induction of
RORγt+Helios− pTregs in the mesenteric lymph nodes (MLN),
Peyer’s patches (PP), small intestine (siLP) and colon lamina
propria (cLP) (Figures 2D,E). C4 colonization also led to an
increase of RORγt+Helios− pTregs in the spleen (Figures 2D,E).
The transcription factor Helios has been suggested to identify
tTregs whereas pTregs are characterized as Helios negative (40,
41). However, it remains controversial whether Helios, or other
markers such as Neuropilin-1 (42, 43), can unequivocally identify
tTregs vs. pTregs (44). We have therefore included expression
of RORγt to better identify microbially-induced pTreg (19–21).
These results indicate that although the microbial communities
of C3 and C4 produced SCFA and induced RORγt+Helios−
pTregs, this was not sufficient to inhibit hyper-IgE.
A More Diverse Microbial Community
Suppresses Hyper-IgE
We have previously demonstrated that bacterial diversity during
early life is important to suppress hyper-IgE (11). Since our
sequential increase of ASF diversity (C1 < C2 < C3 < C4)
had no inhibitory effect on serum IgE levels, we hypothesized
that none of these microbiotas (C1 to C4) reach a high enough
diversity early in life to suppress hyper-IgE. Since the full
ASF showed only partial suppression of hyper-IgE depending
on colonization diversity early in life (11) we hypothesized
that further experimentally increasing the microbial diversity
will eventually result in suppression of hyper-IgE. We recently
established a gnotobiotic microbiota consisting of 12 defined and
well-characterized bacterial species. This microbiota is referred
to as either stable Defined Moderately Diverse Microbiota
from mice (sDMDMm2) (45, 46) or Oligo-mouse microbiota
(Oligo-MM12) (22, 47) (Supplementary Table 3). Analysis of
the microbiota composition in the small intestine and cecum
of our gnotobiotic Oligo-MM12 mouse cohort revealed that
11 of the 12 species were detectable by 16S rRNA amplicon
sequencing (Figure 3A) with Bifidobacterium longum subsp.
animalis YL2 undetectable [as has previously been observed
(22)]. More importantly, however, colonization with the Oligo-
MM12 resulted in suppression of hyper-IgE (Figure 3B), which
correlated with increased production of acetate and propionate
compared to C4-colonized mice while butyrate levels remained
unchanged (Figure 3C). However, the suppression of hyper-IgE
did not reach the levels observed in SPF mice (Figure 2B),
which indicates that increasing bacterial diversity even further
to SPF enhances suppression of hygiene-induced hyper-IgE
(11). Notably, colonization with Oligo-MM12 also resulted in
significant induction of RORγt+Helios− pTregs (Figures 3D,E
and Supplementary Figure 3).
We next followed the Oligo-MM12 colonization dynamics in
early life in the small intestine and colon starting from day 8 until
day 43 after birth (Figure 3F). Up until about 2 weeks of age there
was a dominance of Enterococcus faecalis KB1 and Akkermansia
muciniphila YL44 in both the small intestine and colon. The level
of E. faecalisKB1 then declined drastically concomitantly with an
increase in Bacteroides caecimuris I48 (Figure 3F). These changes
coincided with weaning of the pups, suggesting that the change
in diet from milk to solid food contributes to the increase of
certain bacterial species. In light of our previous findings (11),
these data suggest that the two species (E. faecalis KB1 and A.
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muciniphila YL44) most prominent in early life may contribute
to regulation of IgE levels. In addition, since Clostridia species are
known to be dominant producers of SCFA, and we found that C.
clostridioforme YL32 and Clostridiales species B. coccoides YL58,
were also present in early life, albeit at lower levels, we further
dissected the protective potential of these four bacterial species.
Two Dominant Early Life Clostridiales Are
Unable to Regulate Serum IgE Levels
Since they are often obligate anaerobes, many Clostridiales
species are unable to monocolonize a germ-free gut. We
therefore added B. coccoides YL58 to C2 to generate community
C5 and added C. clostridioforme YL32 to C5 to generate
C6 (Supplementary Table 1). Successful addition of these
species was confirmed by 16S rRNA amplicon sequencing
(Figure 4A). We found that total IgE levels were not altered
from germ-free levels in either C5- or C6-colonized mice
(Figure 4B). Addition of the Clostridiales species also did not
significantly alter SCFA levels compared to C4-colonized mice
(Figure 4C), despite induction of RORγt+Helios− pTregs in
this cohort (Figures 4D,E and Supplementary Figure 4). These
results indicated that other Oligo-MM12 members are likely
contributing to suppression of hyper-IgE.
Acetate Produced by B. coccoides YL58
Contributes to Suppression of Serum IgE
Levels
Since regulation of IgE is dependent on early-life microbial
colonization (11), we next investigated whether E. faecalis KB1
and A. muciniphila YL44, the two most dominant members of
the Oligo-MM12 consortia in early life (Figure 3F), were able
to individually regulate serum IgE levels. We monocolonized
breeding pairs with either E. faecalis KB1 or A. muciniphila
YL44 and determined the serum IgE levels and cecal content
SCFA concentrations in their offspring (Figure 5). Successful
colonization with these individual bacteria was confirmed by 16S
rRNA full length sequencing of DNA extracted from the feces
and by gram staining of intestinal contents (data not shown).
We found that total serum IgE levels in E. faecalis KB1 and
A. muciniphila YL44 monocolonized mice were not significantly
altered from germ-free levels (Figure 5A).
As neither E. faecalis KB1 nor A. muciniphila YL44 by
themselves were able to suppress IgE we next tested these two
in combination. Unfortunately, 16S rRNA amplicon sequencing
of our double-colonized colony revealed that it got contaminated
with the additional Oligo-MM12 species B. coccoides YL58 (YL44
+ KB1 + YL58) (Figure 5B). We did, however, observe a
reduction in serum IgE levels in this YL44 + KB1 + YL58
colony (Figure 5A). To investigate whether this effect relied on
the presence of B. coccoides YL58 we generated B. coccoides
YL58 monocolonized as well as E. faecalis KB1/B. coccoides YL58
(KB1+ YL58) and A. muciniphila YL44/B. coccoides YL58 (YL44
+ YL58) double colonized cohorts. We found that while B.
coccoides YL58 alone was not able to reduce serum IgE levels, we
observed reduced IgE levels when B. coccoides YL58 was present
in combination with E. faecalis KB1 or A. muciniphila YL44
(Figure 5A). This indicated that functional cooperation between
bacterial species with different characteristics was required to
induce an IgE-suppressing effect. Of note, pTreg proportions
in these different cohorts did not correlate with reduced serum
IgE levels indicating that inhibition of IgE was not mediated
solely by induction of pTregs (Supplementary Figures 5, 6). In
addition, the absence of butyrate in all cohorts (Figure 5C), and
the absence of propionate in the KB1 + YL58 model suggests
that propionate and butyrate are not required for suppressing
hygiene-induced hyper-IgE. In contrast, acetate production
correlated with reduced serum IgE levels with the exception
of the B. coccoides YL58 monocolonized group (Figures 5B,C).
Therefore, since B. coccoides YL58 alone was not sufficient to
suppress IgE, we concluded that acetate provided by B. coccoides
YL58 (Figure 5C) is required but not sufficient for reducing IgE
levels. Since E. faecalis KB1 and A. muciniphila YL44 do not
produce high levels of acetate (Figure 5C), we next investigated
what could be the particular characteristics of E. faecalis KB1
and A. muciniphila YL44 that are required to suppress IgE when
present in combination with an acetate-producer.
Immunogenicity Is an Additional
Requirement for IgE Suppression
A recent study identified A. muciniphila as a strong inducer
of systemic IgA and IgG1 (48). We therefore measured serum
IgA and IgG1 reactivity against A. muciniphila YL44 in the
YL44 monocolonized, YL44 + YL58 bicolonized and YL44 +
KB1 + YL58 tricolonized cohorts (Supplementary Figure 7).
All A. muciniphila YL44 colonized cohorts displayed IgA
and IgG1 reactivity against A. muciniphila YL44. While E.
faecalis KB1 monocolonized mice also displayed specific
serum IgA reactivity, B. coccoides YL58 monocolonized mice
did not (Supplementary Figure 7). In order to extend this
immunogenicity screen, we measured total IgA (as opposed
to bacteria-specific IgA) in small intestinal washes and serum
from various gnotobiotic cohorts (Supplementary Figure 8).
We also included segmented filamentous bacteria (SFB)
monocolonized mice as a control as SFB is known to be a
potent inducer of IgA (49). We found that A. muciniphila
YL44, E. faecalis KB1 and SFB were able to promote induction
of IgA (Supplementary Figure 8). Importantly, although SFB
induced a strong IgA response (Supplementary Figure 8)
as well as a RORγt+Helios− pTreg response in the colon,
SFB alone was not sufficient to suppress hygiene-induced
hyper-IgE, possibly due to the lack of acetate production
(Supplementary Figure 9). We therefore conclude that IgA
immunogenicity in combination with acetate production is
required to drive an IgE suppressive phenotype.
IL10 Production Does Not Correlate With
Protection From Hyper IgE
Lastly, we investigated whether IL10 production in the small
intestine, which is required to maintain intestinal immune
homeostasis (50), was required to inhibit hygiene-induced hyper-
IgE. We found similar proportions of IL10+CD45+TCRβ− cells
in the small intestine of cohorts with high vs. low serum
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FIGURE 4 | Two early-life Oligo-MM12 Clostridiales bacteria are unable to regulate serum IgE levels. (A) Relative species abundance in the small intestine (SI) and
cecum of a representative C5- and C6-colonized mouse, n = 2–4 mice per group. (B) Total serum IgE levels in C5 (n = 30) and C6 (n = 49) mice. The blue and
orange horizontal lines represent the geometric mean of the serum IgE levels from the GF and SPF cohorts, respectively (from Figure 1B). (C) SCFA levels in the cecal
(Continued)
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FIGURE 4 | contents of C5 (n = 10–11) and C6 (n = 9) mice. The orange and purple horizontal lines represent the mean SCFA levels in the SPF and C4 cohorts,
respectively (from Figure 1C, 2C). (D) Representative flow cytometry plots of RORγt+Helios− Tregs in different tissues (Spl, spleen; PP, Peyer’s patches; MLN,
mesenteric lymph nodes; SI, small intestinal lamina propria; Col, colon lamina propria) of C5 and C6 mice. (E) Frequencies of RORγt+Helios− Tregs among
CD45+TCRβ+CD4+Foxp3+ cells in different tissues of C5 (n = 4–9) and C6 (n = 3–8) mice. The orange and blue horizontal lines represent the mean frequencies of
RORγt+ Helios− Tregs from the SPF and GF cohorts, respectively (from Figure 2E). All mice were 10–13 weeks old. SCFA and RORγt+Helios− Treg data are pooled
from at least two independent experiments. Each symbol represents an individual mouse. Black horizontal lines depict the geometric mean (B) or mean (C,E). ***p <
0.001, ****p < 0.0001, not significant (ns), calculated by one-way ANOVA with Tukey’s (B,E) or Dunnett’s (C) post-test.
FIGURE 5 | Cooperation between an immunogenic and an acetate-producing species can suppress hyper-IgE. (A) Total serum IgE levels in E. faecalis KB1 (n = 40),
A. muciniphila YL44 (n = 40), B. caecimuris YL58 (n = 46), KB1 + YL58 (n = 23), YL44 + YL58 (n = 28), and KB1 + YL44 + YL58 (n = 61) colonized mice. The blue,
pink, and orange horizontal lines represent the geometric mean of the serum IgE levels from the GF, Oligo-MM12 and SPF mice, respectively (from Figures 1B, 3B).
(B) Relative species abundance in the small intestine (SI) and cecum of a representative KB1 + YL58, YL44 + YL58 and KB1 + YL44 + YL58 mouse, n = 3–4 mice
per group. (C) SCFA levels in the cecal contents of KB1 (n = 4), YL44 (n = 3–4), YL58 (n = 4), KB1 + YL58 (n = 6), YL44 + YL58 (n = 6), and KB1 + YL44 + YL58 (n
= 8–9) colonized mice. The blue, pink, and orange horizontal lines represent the mean SCFA levels from the GF, Oligo-MM12 and SPF cohorts, respectively (from
Figures 1C, 3C). All mice were 10–13 weeks old. SCFA data are pooled from at least two independent experiments. Each symbol represents an individual mouse.
Black horizontal lines depict the geometric mean (A) or mean (C). ***p < 0.001, ****p < 0.0001, not significant (ns), calculated by one-way ANOVA with Tukey’s
post-test (A) or Dunnett’s (C) post-test.
IgE levels indicating that small intestinal IL10 production
alone is not sufficient to suppress hygiene-induced hyper-IgE
(Supplementary Figure 10). In addition, SFB monocolonized
mice, which had the highest proportion of IL10+ cells
(Supplementary Figure 10) retained hygiene-induced hyper-IgE
(Supplementary Figure 9).
In summary, we generated an extensive range of clearly
defined and quality controlled gnotobiotic microbiotas in vivo
in combination with read-outs for serum IgE levels, intestinal
SCFA levels, Treg induction, IgA and IL10 production to identify
characteristics of individual or communities of commensal
bacterial species with the capacity to suppress the hyper-
IgE syndrome observed in germ-free mice. We found that
the IgA-inducing A. muciniphila YL44 and E. faecalis KB1
bacterial species, both dominant in the small intestine in early
life, can cooperate with acetate-producing B. coccoides YL58
to inhibit hyper-IgE. Furthermore, this inhibitory effect was
independent of propionate and butyrate production, frequencies
of IL10+CD45+TCRβ− cells in the small intestinal lamina
propria and frequencies of RORγt+Helios− pTregs in the
intestinal tissues and GALT.
DISCUSSION
Elevated serum IgE levels in germ-free, but also in colonized
immuno-deficient animals, has been a long-standing observation
(8). We have also previously demonstrated that there is a
critical period in early life at around the time of weaning
whereby exposure to a diverse group of microbes is essential to
prevent isotype switching to IgE (11). However, the mechanism
by which this aberrant IgE induction is regulated following
intestinal colonization and which commensal species are potent
Frontiers in Immunology | www.frontiersin.org 11 January 2020 | Volume 10 | Article 3107
Wyss et al. Microbial Regulation of IgE
mediators of protection remains unknown. Here we show
that colonization with A. muciniphila or E. faecalis, that are
both predominantly present before weaning and induce IgA,
in combination with the acetate-producing bacterial species
B. coccoides YL58, results in partial protection from serum
hyper-IgE. Surprisingly, this protection did not correlate with
microbial induction of RORγt+Helios− pTregs in the mucosal
tissues, induction of IL10+CD45+TCRβ− cells, or production of
propionate or butyrate.
We identified induction of IgA and mucosa association
as key characteristics of the bacteria that were involved in
inhibition of IgE. Indeed, both A. muciniphila and E. faecalis
are present near the epithelial surface of the small and large
intestines (51, 52). Although A. muciniphila is known to
have barrier-protective functions (53, 54), it is also a potent
inducer of bacteria-specific systemic IgA and IgG1 responses
(48). Furthermore, decreases in A. muciniphila have been
associated with childhood atopy (55). This indicates that A.
muciniphila is an immunogenic commensal species and this
characteristic contributes to inhibition of hygiene-induced IgE.
In humans, a strong serum IgG response against a common set of
intestinal microbial antigens has been associated with protection
against allergy development during childhood (56). It is also
known that mucosa-association promotes an IgA response (57).
Nevertheless, these characteristics are not sufficient to inhibit IgE
because monocolonization withA. muciniphila, E. faecalis or SFB
failed to reduce IgE levels.
Interestingly, we identified acetate production as a critical
characteristic required for IgE inhibition. B cell class switch to IgE
occurs in the PP in germ-free mice (11) and we found that acetate
(1.9 ± 0.31 µmol/gram), but not butyrate or propionate, and
the acetate-producing bacteria B. coccoides YL58 was present in
the small intestine. In addition, ffar2/gpr43, an acetate receptor,
is also expressed in the small intestine, predominantly on
leukocytes in the lamina propria (58). In humans, acetate was
found to be significantly reduced in infants at 3 months of age
who subsequently developed atopy and wheeze (59) and acetate
has also been identified to be the most abundant SCFA in the
feces of 3–5-month-old infants (60). Therefore, acetate may be
an important bacterial-derived metabolite that regulates early life
immunity, including regulation of IgE.
We have previously shown that there is a critical window
in early life where microbial colonization is required to inhibit
hygiene-induced IgE (11). We now show that the bacteria that
are capable of IgE inhibition are dominant in early life prior
to weaning.
Al Nabhani et al. has recently characterized a vigorous
immune response at weaning, termed the weaning reaction, as
it is associated with changes in the microbiota at weaning (61).
The weaning reaction consists of a time-dependent increase in
tumor necrosis factor alpha (TNF-α) and interferon-γ (IFNγ),
and is driven by bacteria, SCFA and vitamin A (61). Thus, it is
tempting to speculate that a strong weaning reaction induced by
bacteria such as A. muciniphila YL44 and E. faecalis KB1 in the
presence of an acetate-producing bacteria (such as B. coccoides
YL58) during this critical window is sufficient to suppress IgE.
This colonization status could potentially favor IgA and IgG1
isotype class switching events while still inducing the important
RORγt+Helios−pTregs population (61). Although induction of
RORγt+Helios− pTregs at weaning was critical for protection
from inflammation later in life (61), our data indicates that
induction of RORγt+Helios− pTregs alone is insufficient to
inhibit IgE.
Taken together, we show that both bacterial richness and the
presence of key bacterial species in early life are important for
regulating serum IgE. A recent publication has demonstrated
that the increased IgE levels in germ-free mice are induced
by food antigens (62). In context of the weaning reaction
(61) and our findings, this suggests that appropriate bacterial
signals early in life are required to prevent sensitization to
food antigens. Therefore, in addition to the Clostridia species
previously identified (63), our data provides additional bacterial
candidates and avenues for microbial-based prevention strategies
in food allergy.
It is important to note that our bacterial combinations only
provided partial suppression of serum IgE levels and other
additional microbial characteristics are needed to fully inhibit IgE
to the levels found in SPF mice. Therefore, it will be interesting
to further investigate the role of other bacterial characteristics
and metabolites on IgE regulation in order to develop microbial-
based therapeutics for prevention of allergic diseases in humans.
Furthermore, it would be interesting to screen for commensal
species that are dominant in early life, induce IgA and produce
acetate, to see whether these species alone can suppress hyper-
IgE. Unfortunately, thus far we did not come across species with
these capabilities in our extensive in vivo gnotobiotic screen.
Alternatively, once appropriate genetic tools are available, A.
muciniphila YL44 and E. faecalis KB1 can be genetically modified
to produce acetate and tested in isolation.
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